Singapore:Â Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical t...
Singapore: A clinical drug for Huntington's and Alzheimer's disease by Australia-based Prana Biotechnology, a global dev...
Singapore: Australia Minister for Health, Ms Tanya Plibersek, announced that $652 million will be provided for 1,141 gra...
Singapore: Australian vaccine development company BioDiem announced that it has begun research collaboration with France...
Singapore: Australia-based AtCor Medical, the developer and marketer of the SphygmoCor system which measures central aor...
Singapore: How far will a drug company go to fund drug discovery and development? Melborne-based biotechnology company A...
Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its U...
Singapore: Dr Deborah Rathjen, CEO of Australia based Bionomics, was awarded the Life Science Woman Executive of the Yea...
A company that has been leveraging on drug delivery products is Alchemia. Its HyACT technology uses hyaluronic acid's (H...
Singapore: Pfizer will make a phased exit of its West Ryde plant in Australia, which produces tablets and capsules for b...
Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicr...
Singapore: AusBiotech has appointed Mr Lawrence Gozlan as a non-executive director to its board. He has experience in gl...
Singapore:Â Vaxxas, a UniQuest start-up established in 2011 to commercialize the Nanopatch vaccine delivery system bas...
Singapore: Dr Deborah Rathjen, managing director of Bionomics and chair of AusBiotech, has been elected as the chair of ...
Singapore: Australian drug delivery company, Phosphagenics, has received regulatory nod to commence proof of concept of ...
Singapore: Australia-based Phylogica recieved allowance of its US patent application for synthetic Phylomer libraries. T...
Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapi...
Singapore: Scientists at the Walter and Eliza Hall Institute in Melbourne, Australia, have been awarded funding from Can...
Singapore: Australian drug discovery and development company Alchemia reported a record quarterly profit share of $3.5 m...
Singapore: Australia-based Starpharma reported significant tumor-targeting results with its proprietary dendrimer-doceta...
Singapore: Medical technology company iSonea received approval from Australia's Therapeutic Goods Administration (TGA) t...
Singapore: Australia-based ResMed reported record revenue and income for the quarter ending June 30, 2013. Revenue was $...
Singapore: Clinical Network Services (CNS), an Australian-based CRO offering integrated development services, has appoin...
Singapore: Dr Esra Ogru, former chief executive of Phosphagenics has sold her shares in the company to repay $5.7 millio...
Singapore: Bionomics presented data on BNC375, its drug candidate for the treatment of memory loss in Alzheimer's diseas...